Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 545

1.

Dynamic Allostery in PLCγ1 and Its Modulation by a Cancer Mutation Revealed by MD Simulation and NMR.

Koss H, Bunney TD, Esposito D, Martins M, Katan M, Driscoll PC.

Biophys J. 2018 Jul 3;115(1):31-45. doi: 10.1016/j.bpj.2018.05.031.

2.

Global Burden of Stroke.

Katan M, Luft A.

Semin Neurol. 2018 Apr;38(2):208-211. doi: 10.1055/s-0038-1649503. Epub 2018 May 23.

PMID:
29791947
3.

NMR backbone assignments of the tyrosine kinase domain of human fibroblast growth factor receptor 3 in apo state and in complex with inhibitor PD173074.

Sanfelice D, Koss H, Bunney TD, Thompson GS, Farrell B, Katan M, Breeze AL.

Biomol NMR Assign. 2018 Mar 26. doi: 10.1007/s12104-018-9814-7. [Epub ahead of print]

PMID:
29582384
4.

Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.

Bunney TD, Inglis AJ, Sanfelice D, Farrell B, Kerr CJ, Thompson GS, Masson GR, Thiyagarajan N, Svergun DI, Williams RL, Breeze AL, Katan M.

Structure. 2018 Mar 6;26(3):446-458.e8. doi: 10.1016/j.str.2018.01.016. Epub 2018 Feb 22.

5.

Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.

De Marchis GM, Schneider J, Weck A, Fluri F, Fladt J, Foerch C, Mueller B, Luft A, Christ-Crain M, Arnold M, Katan M.

Neurology. 2018 Feb 6;90(6):e455-e465. doi: 10.1212/WNL.0000000000004922. Epub 2018 Jan 10.

PMID:
29321236
6.

Serum neurofilament light chain in patients with acute cerebrovascular events.

De Marchis GM, Katan M, Barro C, Fladt J, Traenka C, Seiffge DJ, Hert L, Gensicke H, Disanto G, Sutter R, Peters N, Sarikaya H, Goeggel-Simonetti B, El-Koussy M, Engelter S, Lyrer PA, Christ-Crain M, Arnold M, Kuhle J, Bonati LH.

Eur J Neurol. 2018 Mar;25(3):562-568. doi: 10.1111/ene.13554. Epub 2018 Jan 24.

PMID:
29281157
7.

[City hall holds the key to weight control].

Katan MB.

Ned Tijdschr Geneeskd. 2017;161(0):B1445. Dutch.

PMID:
29271314
8.

Unique signalling connectivity of FGFR3-TACC3 oncoprotein revealed by quantitative phosphoproteomics and differential network analysis.

Lombardi B, Ashford P, Moya-Garcia AA, Rust A, Crawford M, Williams SV, Knowles MA, Katan M, Orengo C, Godovac-Zimmermann J.

Oncotarget. 2017 Oct 25;8(61):102898-102911. doi: 10.18632/oncotarget.22048. eCollection 2017 Nov 28.

9.

Getting the First Grant.

Wegener S, Katan M.

Stroke. 2018 Jan;49(1):e7-e9. doi: 10.1161/STROKEAHA.117.019897. Epub 2017 Dec 6. No abstract available.

10.

Selection bias in clinical stroke trials depending on ability to consent.

Hotter B, Ulm L, Hoffmann S, Katan M, Montaner J, Bustamante A, Meisel A.

BMC Neurol. 2017 Dec 4;17(1):206. doi: 10.1186/s12883-017-0989-9.

11.

MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke.

Scherrer N, Fays F, Mueller B, Luft A, Fluri F, Christ-Crain M, Devaux Y, Katan M.

J Stroke. 2017 Sep;19(3):323-332. doi: 10.5853/jos.2017.00423. Epub 2017 Sep 29.

12.

Why Is It Worthwhile to Get Involved in Stroke Organizations?

Schmidt A, Katan M, Sandset EC.

Stroke. 2017 Oct;48(10):e277-e279. doi: 10.1161/STROKEAHA.117.018850. Epub 2017 Sep 13. Review. No abstract available.

13.

Coming to the United States for a Stroke Research Fellowship.

Li Z, Katan M.

Stroke. 2017 Aug;48(8):e190-e192. doi: 10.1161/STROKEAHA.117.018084. Epub 2017 Jul 13. No abstract available.

14.

Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study.

Azurmendi L, Lapierre-Fetaud V, Schneider J, Montaner J, Katan M, Sanchez JC.

Clin Proteomics. 2017 Jul 12;14:27. doi: 10.1186/s12014-017-9162-0. eCollection 2017.

15.

[Fish oil in pregnancy: can it prevent asthma in children?]

Brand PLP, Katan MB.

Ned Tijdschr Geneeskd. 2017;161(0):D1616. Dutch.

PMID:
28635579
16.

The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke.

Ulm L, Hoffmann S, Nabavi D, Hermans M, Mackert BM, Hamilton F, Schmehl I, Jungehuelsing GJ, Montaner J, Bustamante A, Katan M, Hartmann A, Ebmeyer S, Dinter C, Wiemer JC, Hertel S, Meisel C, Anker SD, Meisel A.

Front Neurol. 2017 Apr 24;8:153. doi: 10.3389/fneur.2017.00153. eCollection 2017.

17.

Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study.

Blum CA, Winzeler B, Nigro N, Schuetz P, Biethahn S, Kahles T, Mueller C, Timper K, Haaf K, Tepperberg J, Amort M, Huber A, Bingisser R, Sándor PS, Nedeltchev K, Müller B, Katan M, Christ-Crain M.

J Headache Pain. 2017 Dec;18(1):21. doi: 10.1186/s10194-017-0733-2. Epub 2017 Feb 13.

18.

C-reactive protein in the detection of post-stroke infections: systematic review and individual participant data analysis.

Bustamante A, Vilar-Bergua A, Guettier S, Sánchez-Poblet J, García-Berrocoso T, Giralt D, Fluri F, Topakian R, Worthmann H, Hug A, Molnar T, Waje-Andreassen U, Katan M, Smith CJ, Montaner J.

J Neurochem. 2017 Apr;141(2):305-314. doi: 10.1111/jnc.13973. Epub 2017 Mar 8. Review.

19.

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Katan M, Moon Y, von Eckardstein A, Spanaus K, DeRosa J, Gutierrez J, DeCarli C, Wright C, Sacco R, Elkind M.

Stroke. 2017 Mar;48(3):604-610. doi: 10.1161/STROKEAHA.116.014945. Epub 2017 Jan 25.

20.

Conformational transition of FGFR kinase activation revealed by site-specific unnatural amino acid reporter and single molecule FRET.

Perdios L, Lowe AR, Saladino G, Bunney TD, Thiyagarajan N, Alexandrov Y, Dunsby C, French PM, Chin JW, Gervasio FL, Tate EW, Katan M.

Sci Rep. 2017 Jan 3;7:39841. doi: 10.1038/srep39841.

21.

Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.

Kelly PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, Ferrari J, George P, Katan M, Knoflach M, Kim JS, Li L, Lee EJ, Olivot JM, Purroy F, Raposo N, Rothwell PM, Sharma VK, Song B, Tsivgoulis G, Walsh C, Xu Y, Merwick A.

Lancet Neurol. 2016 Nov;15(12):1238-1247. doi: 10.1016/S1474-4422(16)30236-8. Epub 2016 Oct 11.

PMID:
27751555
22.

Corrigendum: Screening for protein-protein interactions using Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM).

Margineanu A, Chan JJ, Kelly DJ, Warren SC, Flatters D, Kumar S, Katan M, Dunsby CW, French PM.

Sci Rep. 2016 Sep 22;6:33621. doi: 10.1038/srep33621. No abstract available.

23.

Impact of Masked Replacement of Sugar-Sweetened with Sugar-Free Beverages on Body Weight Increases with Initial BMI: Secondary Analysis of Data from an 18 Month Double-Blind Trial in Children.

Katan MB, de Ruyter JC, Kuijper LD, Chow CC, Hall KD, Olthof MR.

PLoS One. 2016 Jul 22;11(7):e0159771. doi: 10.1371/journal.pone.0159771. eCollection 2016.

24.

Screening for protein-protein interactions using Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM).

Margineanu A, Chan JJ, Kelly DJ, Warren SC, Flatters D, Kumar S, Katan M, Dunsby CW, French PM.

Sci Rep. 2016 Jun 24;6:28186. doi: 10.1038/srep28186. Erratum in: Sci Rep. 2016 Sep 22;6:33621.

25.

Quantitative in vivo optical tomography of cancer progression & vasculature development in adult zebrafish.

Kumar S, Lockwood N, Ramel MC, Correia T, Ellis M, Alexandrov Y, Andrews N, Patel R, Bugeon L, Dallman MJ, Brandner S, Arridge S, Katan M, McGinty J, Frankel P, French PM.

Oncotarget. 2016 Jul 12;7(28):43939-43948. doi: 10.18632/oncotarget.9756.

26.

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Mueller B, Huber A, Sacco RL, Elkind MS.

Stroke. 2016 Jul;47(7):1714-9. doi: 10.1161/STROKEAHA.115.011392. Epub 2016 May 19.

27.

Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.

Patani H, Bunney TD, Thiyagarajan N, Norman RA, Ogg D, Breed J, Ashford P, Potterton A, Edwards M, Williams SV, Thomson GS, Pang CS, Knowles MA, Breeze AL, Orengo C, Phillips C, Katan M.

Oncotarget. 2016 Apr 26;7(17):24252-68. doi: 10.18632/oncotarget.8132.

28.

Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome.

Urwyler SA, Timper K, Fenske W, de Mota N, Blanchard A, Kühn F, Frech N, Arici B, Rutishauser J, Kopp P, Stettler C, Müller B, Katan M, Llorens-Cortes C, Christ-Crain M.

J Clin Endocrinol Metab. 2016 May;101(5):1917-23. doi: 10.1210/jc.2016-1158. Epub 2016 Mar 11.

PMID:
26967692
29.

[The Dietary Guidelines 2015 of the Health Council of the Netherlands--a commentary].

Katan MB.

Ned Tijdschr Geneeskd. 2015;159:A9802. Dutch.

PMID:
26606586
30.

Global Profiling of Huntingtin-associated protein E (HYPE)-Mediated AMPylation through a Chemical Proteomic Approach.

Broncel M, Serwa RA, Bunney TD, Katan M, Tate EW.

Mol Cell Proteomics. 2016 Feb;15(2):715-25. doi: 10.1074/mcp.O115.054429. Epub 2015 Nov 24.

31.

Time-resolved FRET reports FGFR1 dimerization and formation of a complex with its effector PLCγ1.

Perdios L, Bunney TD, Warren SC, Dunsby C, French PMW, Tate EW, Katan M.

Adv Biol Regul. 2016 Jan;60:6-13. doi: 10.1016/j.jbior.2015.09.002. Epub 2015 Sep 26.

32.

Accelerated Optical Projection Tomography Applied to In Vivo Imaging of Zebrafish.

Correia T, Lockwood N, Kumar S, Yin J, Ramel MC, Andrews N, Katan M, Bugeon L, Dallman MJ, McGinty J, Frankel P, French PM, Arridge S.

PLoS One. 2015 Aug 26;10(8):e0136213. doi: 10.1371/journal.pone.0136213. eCollection 2015.

33.

Homo-FRET Based Biosensors and Their Application to Multiplexed Imaging of Signalling Events in Live Cells.

Warren SC, Margineanu A, Katan M, Dunsby C, French PM.

Int J Mol Sci. 2015 Jun 30;16(7):14695-716. doi: 10.3390/ijms160714695.

34.

The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study.

Bunney TD, Wan S, Thiyagarajan N, Sutto L, Williams SV, Ashford P, Koss H, Knowles MA, Gervasio FL, Coveney PV, Katan M.

EBioMedicine. 2015 Mar 1;2(3):194-204.

35.
36.

Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.

Timper K, Fenske W, Kühn F, Frech N, Arici B, Rutishauser J, Kopp P, Allolio B, Stettler C, Müller B, Katan M, Christ-Crain M.

J Clin Endocrinol Metab. 2015 Jun;100(6):2268-74. doi: 10.1210/jc.2014-4507. Epub 2015 Mar 13.

PMID:
25768671
37.

Can children discriminate sugar-sweetened from non-nutritively sweetened beverages and how do they like them?

de Ruyter JC, Katan MB, Kas R, Olthof MR.

PLoS One. 2014 Dec 31;9(12):e115113. doi: 10.1371/journal.pone.0115113. eCollection 2014.

38.

PLCγ1 participates in protein transport and diacylglycerol production triggered by cargo arrival at the Golgi.

Sicart A, Katan M, Egea G, Sarri E.

Traffic. 2015 Mar;16(3):250-66. doi: 10.1111/tra.12246. Epub 2015 Jan 6.

39.

Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage.

Senn R, Elkind MS, Montaner J, Christ-Crain M, Katan M.

Cerebrovasc Dis. 2014;38(6):395-409. doi: 10.1159/000366470. Epub 2014 Dec 3. Review.

40.

Dysfunction of phospholipase Cγ in immune disorders and cancer.

Koss H, Bunney TD, Behjati S, Katan M.

Trends Biochem Sci. 2014 Dec;39(12):603-11. doi: 10.1016/j.tibs.2014.09.004. Epub 2014 Oct 30. Review.

PMID:
25456276
41.

Crystal structure of the human, FIC-domain containing protein HYPE and implications for its functions.

Bunney TD, Cole AR, Broncel M, Esposito D, Tate EW, Katan M.

Structure. 2014 Dec 2;22(12):1831-1843. doi: 10.1016/j.str.2014.10.007.

42.

Association of dietary, circulating, and supplement fatty acids with coronary risk.

Liebman BF, Katan MB, Jacobson MF.

Ann Intern Med. 2014 Sep 16;161(6):454-5. doi: 10.7326/L14-5018-4. No abstract available.

PMID:
25222396
43.

Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.

De Marchis GM, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler NG, Mattle HP, Mueller B, Christ-Crain M, Arnold M, Katan M.

Stroke. 2014 Oct;45(10):2918-23. doi: 10.1161/STROKEAHA.114.005584. Epub 2014 Aug 28.

44.

BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events.

Nigro N, Wildi K, Mueller C, Schuetz P, Mueller B, Fluri F, Christ-Crain M, Katan M.

PLoS One. 2014 Jul 29;9(7):e102704. doi: 10.1371/journal.pone.0102704. eCollection 2014.

46.

Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study.

Frontzek K, Fluri F, Siemerkus J, Müller B, Gass A, Christ-Crain M, Katan M.

PLoS One. 2014 Mar 19;9(3):e92421. doi: 10.1371/journal.pone.0092421. eCollection 2014.

47.

Recurrent PTPRB and PLCG1 mutations in angiosarcoma.

Behjati S, Tarpey PS, Sheldon H, Martincorena I, Van Loo P, Gundem G, Wedge DC, Ramakrishna M, Cooke SL, Pillay N, Vollan HKM, Papaemmanuil E, Koss H, Bunney TD, Hardy C, Joseph OR, Martin S, Mudie L, Butler A, Teague JW, Patil M, Steers G, Cao Y, Gumbs C, Ingram D, Lazar AJ, Little L, Mahadeshwar H, Protopopov A, Al Sannaa GA, Seth S, Song X, Tang J, Zhang J, Ravi V, Torres KE, Khatri B, Halai D, Roxanis I, Baumhoer D, Tirabosco R, Amary MF, Boshoff C, McDermott U, Katan M, Stratton MR, Futreal PA, Flanagan AM, Harris A, Campbell PJ.

Nat Genet. 2014 Apr;46(4):376-379. doi: 10.1038/ng.2921. Epub 2014 Mar 16.

48.

Tumor suppressor role of phospholipase C epsilon in Ras-triggered cancers.

Martins M, McCarthy A, Baxendale R, Guichard S, Magno L, Kessaris N, El-Bahrawy M, Yu P, Katan M.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4239-44. doi: 10.1073/pnas.1311500111. Epub 2014 Mar 3.

49.

The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.

Fischer M, Katan M, Morgenthaler NG, Seiler M, Müller B, Lackner P, Errath M, Helbok R, Pfausler B, Beer R, Schmutzhard E, Broessner G.

Cerebrovasc Dis. 2014;37(2):128-33. doi: 10.1159/000357215. Epub 2014 Jan 30.

50.

Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Wolfert RL, Sacco RL, Elkind MS.

PLoS One. 2014 Jan 9;9(1):e83393. doi: 10.1371/journal.pone.0083393. eCollection 2014.

Supplemental Content

Support Center